Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
447.5 USD | +1.25% | +2.29% | +9.99% |
22/05 | Vertex Pharmaceuticals Insider Sold Shares Worth $6,795,294, According to a Recent SEC Filing | MT |
21/05 | ADDvise Group’s Axelerist Bags $1.4 Million Order for Medical, Lab Equipment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.99% | 12TCr | |
+12.01% | 11TCr | |
-3.07% | 2.47TCr | |
-0.93% | 2.2TCr | |
-5.71% | 1.93TCr | |
-6.90% | 1.76TCr | |
-39.36% | 1.73TCr | |
+5.82% | 1.4TCr | |
+33.05% | 1.21TCr | |
+13.63% | 776.36Cr |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Vertex Pharmaceuticals : RBC Lowers Price Target on Vertex Pharmaceuticals to $246 From $248, Maintains Outperform Rating